GSK-GLP116174

Study Sponsor: GSK

Study Title

A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP116174

Trial Registry Identification Number(#'s)

NCT02465515 2014-001824-32

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 4

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=116174

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02465515

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2014-001824-32

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC Format. An annotated case report form is not available. A blank case report form will be provided. There is a Publication Steering Committee for this study. Data for some subjects is not available due to lack of consent.

Date Added to this Site

February 2019